Immunosuppression in multiple myeloma may not increase melanoma risk

Source: Healio, November 2017

Although immunosuppression associated with multiple myeloma may not predispose patients to melanoma, other immunosuppressed states may increase melanoma risk, according to recent findings.
Researchers assessed patients from 13 registries in the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. The analysis included 31,622 patients diagnosed with multiple myeloma between Jan. 1, 1992, and Dec. 31, 2010.
Results showed an incidence of subsequent melanoma of 64.9 per 100,000 person-years (95% CI, 49.8-83) in this patient population.